Correction: Velickovic et al. The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation. Biomedicines 2025, 13, 512

Uros Velickovic; Dragica Selakovic; Nemanja Jovicic; Marina Mitrovic; Vladimir Janjic; Sara Rosic; Suzana Randjelovic; Dragan Milovanovic; Gvozden Rosic

doi:10.3390/biomedicines13092216

,

and

¹

Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia

²

Department of Histology and Embryology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia

³

Department of Medical Biochemistry, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia

⁴

Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia

Biomedicines2025, 13(9), 2216;https://doi.org/10.3390/biomedicines13092216

This article belongs to the Special Issue Animal Models of Neurological Disorders: Where Are We Now? (2nd Edition)

Version Notes

Order Reprints

The authors would like to make the following corrections to this published paper [1]:

Instead of the following retracted Ref. [24] in the paper:

Taylor, D.M.; Velaga, S.; Werneke, U. Reducing the stigma of long acting injectable antipsychotics—Current concepts and future developments. Nord. J. Psychiatry 2018, 72 (Suppl. S1), S36–S39.

We have now included the following [2]:

Nadesalingam, N.; Chapellier, V.; Lefebvre, S.; Pavlidou, A.; Stegmayer, K.; Alexaki, D.; Gama, D.B.; Maderthaner, L.; von Känel, S.; Wüthrich, F.; et al. Motor abnormalities are associated with poor social and functional outcomes in schizophrenia. Comp. Psychiatry 2022, 115, 152307.

There are no changes to the order of references. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

References

Velickovic, U.; Selakovic, D.; Jovicic, N.; Mitrovic, M.; Janjic, V.; Rosic, S.; Randjelovic, S.; Milovanovic, D.; Rosic, G. The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation. Biomedicines 2025, 13, 512. [Google Scholar] [CrossRef] [PubMed]
Nadesalingam, N.; Chapellier, V.; Lefebvre, S.; Pavlidou, A.; Stegmayer, K.; Alexaki, D.; Gama, D.B.; Maderthaner, L.; von Känel, S.; Wüthrich, F.; et al. Motor abnormalities are associated with poor social and functional outcomes in schizophrenia. Comp. Psychiatry 2022, 115, 152307. [Google Scholar] [CrossRef] [PubMed]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Correction: Velickovic et al. The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation. Biomedicines 2025, 13, 512

References

Article Metrics

Citations

Article Access Statistics